| 000 | 01670 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518013437.0 | ||
| 264 | 0 | _c20200907 | |
| 008 | 202009s 0 0 eng d | ||
| 022 | _a1463-1326 | ||
| 024 | 7 |
_a10.1111/dom.13616 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTibaldi, Joseph | |
| 245 | 0 | 0 |
_aA comparative effectiveness study of degludec and insulin glargine 300 U/mL in insulin-naïve patients with type 2 diabetes. _h[electronic resource] |
| 260 |
_bDiabetes, obesity & metabolism _c04 2019 |
||
| 300 |
_a1001-1009 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
| 650 | 0 | 4 | _aComparative Effectiveness Research |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemia _xchemically induced |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aInsulin Glargine _xtherapeutic use |
| 650 | 0 | 4 |
_aInsulin, Long-Acting _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aAssessment of Medication Adherence |
| 700 | 1 | _aHadley-Brown, Martin | |
| 700 | 1 | _aLiebl, Andreas | |
| 700 | 1 | _aHaldrup, Steffen | |
| 700 | 1 | _aSandberg, Viktor | |
| 700 | 1 | _aWolden, Michael L | |
| 700 | 1 | _aRodbard, Helena W | |
| 773 | 0 |
_tDiabetes, obesity & metabolism _gvol. 21 _gno. 4 _gp. 1001-1009 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/dom.13616 _zAvailable from publisher's website |
| 999 |
_c29165681 _d29165681 |
||